BlackRock Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$21M Buy
717,577
+33,782
+5% +$922K 0.02% 550
2016
Q3
$18.6M Buy
683,795
+154,944
+29% +$3.5M 0.02% 564
2016
Q2
$9.87M Buy
528,851
+44,212
+9% +$922K 0.01% 832
2016
Q1
$13.1M Buy
484,639
+41,738
+9% +$1.2M 0.01% 691
2015
Q4
$13.3M Sell
442,901
-3,815
-0.9% -$122K 0.01% 690
2015
Q3
$14.1M Buy
446,716
+19,310
+5% +$705K 0.02% 642
2015
Q2
$16.6M Buy
427,406
+29,819
+7% +$1.03M 0.02% 587
2015
Q1
$14.1M Buy
397,587
+67,967
+21% +$2.19M 0.01% 687
2014
Q4
$10.4M Buy
329,620
+10,158
+3% +$281K 0.01% 773
2014
Q3
$7.16M Sell
319,462
-34,141
-10% -$684K 0.01% 877
2014
Q2
$7.76M Buy
+353,603
New +$6.72M 0.01% 857

Other funds holding PAHC

BlackRock Advisors's PAHC Position: Q4 2016 in Review

BlackRock Advisors increased its Phibro Animal Health (PAHC) stake by 4.9% in Q4 2016, buying an estimated $922K and bringing the position to 717,577 shares worth $21M. The position accounts for 0.02% of the portfolio, ranked #550.

BlackRock Advisors first reported a position in PAHC in Q2 2014 and has held it in 11 quarters since. 143 funds tracked by Wall St. Rank hold PAHC as of Q4 2016.

  • BlackRock Advisors held 717,577 shares of Phibro Animal Health worth $21M as of Q4 2016.
  • BlackRock Advisors bought 33,782 Phibro Animal Health shares in Q4 2016, an estimated $922K.
  • Phibro Animal Health made up 0.02% of BlackRock Advisors's portfolio in Q4 2016, its #550 holding.
  • BlackRock Advisors first reported a position in Phibro Animal Health in Q2 2014 and has held it in 11 quarters since.
  • 143 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.